361 related articles for article (PubMed ID: 10362352)
1. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
2. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
[TBL] [Abstract][Full Text] [Related]
3. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
Kohda A; Yamazaki S; Sumimoto H
J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
[TBL] [Abstract][Full Text] [Related]
4. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
EMBO J; 1993 Oct; 12(10):3893-901. PubMed ID: 8404857
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
[TBL] [Abstract][Full Text] [Related]
8. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
Jiang HY; Petrovas C; Sonenshein GE
J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
[TBL] [Abstract][Full Text] [Related]
9. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
Pan J; McEver RP
J Biol Chem; 1995 Sep; 270(39):23077-83. PubMed ID: 7559449
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.
Latimer M; Ernst MK; Dunn LL; Drutskaya M; Rice NR
Mol Cell Biol; 1998 May; 18(5):2640-9. PubMed ID: 9566883
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
14. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.
Li Z; Nabel GJ
Mol Cell Biol; 1997 Oct; 17(10):6184-90. PubMed ID: 9315679
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.
Montano MA; Kripke K; Norina CD; Achacoso P; Herzenberg LA; Roy AL; Nolan GP
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12376-81. PubMed ID: 8901589
[TBL] [Abstract][Full Text] [Related]
16. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
Wessells J; Baer M; Young HA; Claudio E; Brown K; Siebenlist U; Johnson PF
J Biol Chem; 2004 Nov; 279(48):49995-50003. PubMed ID: 15465827
[TBL] [Abstract][Full Text] [Related]
17. The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.
Keutgens A; Shostak K; Close P; Zhang X; Hennuy B; Aussems M; Chapelle JP; Viatour P; Gothot A; Fillet M; Chariot A
Mol Cell Biol; 2010 Aug; 30(16):4006-21. PubMed ID: 20547759
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation.
Zwollo P; Rao S; Wallin JJ; Gackstetter ER; Koshland ME
J Biol Chem; 1998 Jul; 273(29):18647-55. PubMed ID: 9660839
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.
Caamaño JH; Perez P; Lira SA; Bravo R
Mol Cell Biol; 1996 Apr; 16(4):1342-8. PubMed ID: 8657107
[TBL] [Abstract][Full Text] [Related]
20. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
